Hilgers, A, Krueger, G R, Lembke, U et al. · In vivo (Athens, Greece) · 1991
This study followed 35 ME/CFS patients in Germany for up to eight years and found that most experienced severe fatigue, joint and muscle pain, sore throats, and various other symptoms. Researchers found evidence of herpesvirus reactivation in about 73% of patients and Epstein-Barr virus in about 34%, suggesting ongoing viral activity may play a role in the condition. While treatments were tried including immune therapy and antiviral drugs, none consistently worked well, though immune globulin therapy showed the most promise.
This study from the early post-CFS-definition era provides evidence linking ME/CFS to persistent or recurrent viral reactivation, particularly HHV-6, which has remained a focus of research. It documents that the condition involves multiple biological systems beyond fatigue alone and highlights why comprehensive, individualized approaches may be necessary rather than one-size-fits-all treatments.
This study does not prove that viruses cause ME/CFS, only that they are frequently present in affected individuals—causation remains unclear. The variable immunologic findings and treatment failures mean we cannot conclude what the underlying mechanism is or which treatments definitively work. Small sample size and lack of age/sex-matched controls limit how well these results apply to the broader ME/CFS population.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.